References
1. JW.org. How Many Jehovah’s Witnesses Are There Worldwide?
https://www.jw.org/en/jehovahs-witnesses/faq/how-many-jw/. Published
2019. Accessed 18 August, 2020.
2. Marinakis S, Van der Linden P, Tortora R, Massaut J, Pierrakos C,
Wauthy P. Outcomes from cardiac surgery in Jehovah’s witness patients:
experience over twenty-one years. J Cardiothorac Surg. 2016;11(1):67.
3. McCartney S, Guinn N, Roberson R, Broomer B, White W, Hill S.
Jehovah’s Witnesses and cardiac surgery: a single institution’s
experience. Transfusion. 2014;54(10 Pt 2):2745-2752.
4. Moraca RJ, Wanamaker KM, Bailey SH, et al. Strategies and outcomes of
cardiac surgery in Jehovah’s Witnesses. J Card Surg. 2011;26(2):135-143.
5. Rosseel P. The Jehovah’s Witness. In: von Heymann C. BC, ed. Patient
Blood Management in Cardiac Surgery Springer, Cham; 2019:147-159.
6. JW.org. Charles Taze Russell—Founder of Jehovah’s Witnesses? .
https://www.jw.org/en/jehovahs-witnesses/faq/founder/. Published 2020.
Accessed 20 August 2020.
7. JW.org. What Is the Governing Body of Jehovah’s Witnesses? Current
Member List and Helpers.
https://www.jw.org/en/jehovahs-witnesses/faq/governing-body-jw-helpers/.
Published 2020. Accessed 20 August 2020.
8. Duce L, Cooter ML, McCartney SL, Lombard FW, Guinn NR. Outcomes in
Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received
Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study.
Anesth Analg. 2018;127(2):490-495.
9. JW.org. What Is the Watch Tower Bible and Tract Society?
https://www.jw.org/en/jehovahs-witnesses/faq/watchtower-society/.
Published 2020. Accessed 18 August, 2020.
10. Cooper L, Ford K, Miller E. Preparing a Jehovah’s Witness for major
elective surgery. BMJ. 2013;346:f1588.
11. Joint United Kingdom (UK) Blood Transfusion and Tissue
Transplantation Services Professional Advisory Committee.Transfusion Handbook. 2014.
12. Papalexopoulou N, Attia RQ, Bapat VN. Successful surgical repair of
acute type A aortic dissection without the use of blood products. Ann R
Coll Surg Engl. 2013;95(7):127-129.
13. Cooley DA, Crawford ES, Howell JF, Beall AC, Jr. Open Heart Surgery
in Jehovah’s Witnesses. Am J Cardiol. 1964;13:779-781.
14. Lewis CT, Murphy MC, Cooley DA. Risk factors for cardiac operations
in adult Jehovah’s Witnesses. Ann Thorac Surg. 1991;51(3):448-450.
15. Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who
refuse transfusion after cardiac surgery: a natural experiment with
severe blood conservation. Arch Intern Med. 2012;172(15):1154-1160.
16. Vaislic CD, Dalibon N, Ponzio O, et al. Outcomes in cardiac surgery
in 500 consecutive Jehovah’s Witness patients: 21 year experience. J
Cardiothorac Surg. 2012;7:95.
17. Goobie SM, DiNardo JA, Faraoni D. Relationship between transfusion
volume and outcomes in children undergoing noncardiac surgery.
Transfusion. 2016;56(10):2487-2494.
18. Mazine A, Rached-D’Astous S, Ducruet T, et al. Blood Transfusions
After Pediatric Cardiac Operations: A North American Multicenter
Prospective Study. Ann Thorac Surg. 2015;100(2):671-677.
19. Huebler M, Habazettl H, Boettcher W, Kuppe H, Hetzer R, Redlin M.
Transfusion-free complex cardiac surgery: with use of deep hypothermic
circulatory arrest in a preterm 2.96-kg Jehovah’s witness neonate. Tex
Heart Inst J. 2011;38(5):562-564.
20. Olshove V, Berndsen N, Sivarajan V, Nawathe P, Phillips A.
Comprehensive blood conservation program in a new congenital cardiac
surgical program allows bloodless surgery for the Jehovah Witness and a
reduction for all patients. Perfusion. 2018;33(3):194-202.
21. Doyle DJ. Blood transfusions and the Jehovah’s Witness patient. Am J
Ther. 2002;9(5):417-424.
22. The Royal College of Surgeons of England. Caring for patients who
refuse blood - a guide to good practice. London, UK 2016.
23. Preston TJ, Olshove VF, Jr., Chase M. Bloodless extracorporeal
membrane oxygenation in the Jehovah’s Witness patient. J Extra Corpor
Technol. 2012;44(1):39-42.
24. Summers J. Principles of Healthcare Ethics. In: Morrison EE, ed.
Health Care Ethics: Critical Issues for the 21st Century. 2nd ed.
Sudbury, MA: Jones and Bartlett Publishers; 2009:41-58.
25. Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J. Bleeding in
a Jehovah’s Witness patient undergoing a redo aortic valve replacement
controlled with cryoprecipitate and a prothrombin complex concentrate.
Can J Anaesth. 2012;59(3):299-303.
26. Tanaka A, Ota T, Uriel N, et al. Cardiovascular surgery in Jehovah’s
Witness patients: The role of preoperative optimization. J Thorac
Cardiovasc Surg. 2015;150(4):976-983 e971-973.
27. Teodori J, Rampersad K, Teodori G, et al. Redo Triple Coronary
Artery Bypass Graft on a Jehovah’s Witness Patient: A “Tailored”
Approach. WIMJ Open. 2014;1(1):9-10.
28. National Instiute for Health and Care Excellence (NICE). Blood
Transfusion. In:2015: https://www.nice.org.uk/guidance/ng24. Accessed 20
August 2020.
29. Marshall L, Krampl C, Vrtik M, et al. Short term outcomes after
cardiac surgery in a Jehovah’s Witness population: an institutional
experience. Heart Lung Circ. 2012;21(2):101-104.
30. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for
minimising perioperative allogeneic blood transfusion. Cochrane Database
Syst Rev. 2011(3):CD001886.
31. Rispoli M, Bergaminelli C, Nespoli MR, et al. Major thoracic surgery
in Jehovah’s witness: A multidisciplinary approach case report. Int J
Surg Case Rep. 2016;23:116-119.
32. Park JJ, Lang CC, Manson L, Brackenbury ET. Aortic valve replacement
in a Jehovah’s Witness: a case of multi-disciplinary clinical management
for bloodless surgery. BMJ Case Rep. 2012;2012.
33. Valleley MS, Glogowski KR, Duncan KF, Dutoit A, Hagedorn C.
Bloodless Repair of Aortic Arch with Dual Aortic Cannulation in a
Jehovah’s Witness Patient. J Extra Corpor Technol. 2017;49(3):206-209.
34. Kitahara H, Ota T, Jeevanandam V. Complex Cardiac Surgery Without
Blood Transfusions: Lessons Learned from Managing Jehovah Witness
Patients. In: Lonchyna V, ed. Difficult Decisions in Cardiothoracic
Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based
Approach. Springer, Cham; 2019.
35. Tinegate H, Birchall J, Gray A, et al. Guideline on the
investigation and management of acute transfusion reactions. Prepared by
the BCSH Blood Transfusion Task Force. Br J Haematol.
2012;159(2):143-153.
36. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham
SJ. Effect of blood transfusion on long-term survival after cardiac
operation. Ann Thorac Surg. 2002;74(4):1180-1186.
37. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery
bypass grafting is associated with reduced long-term survival. Ann
Thorac Surg. 2006;81(5):1650-1657.
38. Shaw RE, Johnson CK, Ferrari G, et al. Balancing the benefits and
risks of blood transfusions in patients undergoing cardiac surgery: a
propensity-matched analysis. Interact Cardiovasc Thorac Surg.
2013;17(1):96-102.
39. General Medical Council (GMC). Good Medical Practice.
https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/good-medical-practice.
Published 2020. Accessed 20 August, 2020.
40. Kim TS, Lee JH, An H, Na CY. Transfusion Risk and Clinical Knowledge
(TRACK) Score and Cardiac Surgery in Patients Refusing Transfusion. J
Cardiothorac Vasc Anesth. 2016;30(2):373-378.
41. Kang S-H, Song I, Kang J-E, Lee J-H, Kim J-T. Anesthetic management
for transfusion-free Rastelli’s procedure in a pediatric Jehovah’s
Witness patient. Korean journal of anesthesiology. 2013;65(6
Suppl):S87-S88.
42. Binder RK, Barbanti M, Ye J, et al. Blood loss and transfusion rates
associated with transcatheter aortic valve replacement: recommendations
for patients who refuse blood transfusion. Catheter Cardiovasc Interv.
2014;83(6):E221-226.
43. Juraszek A, Kolsut P, Szymanski J, et al. Results of open heart
surgery in Jehovah’s Witness patients. Single centre experience.
Kardiochir Torakochirurgia Pol. 2017;14(3):164-169.
44. Bhaskar B, Jack RK, Mullany D, Fraser J. Comparison of outcome in
Jehovah’s Witness patients in cardiac surgery: an Australian experience.
Heart Lung Circ. 2010;19(11):655-659.
45. DeCoste R, Mingo H, Kent B, Legare JF, Buth K, Kwapisz M. Jehovah’s
Witness Patients in Cardiac Surgery: A Retrospective Chart Review.
Journal of Anesthesia and Advanced Research. 2018;1(1).
46. Guinn NR, Roberson RS, White W, et al. Costs and outcomes after
cardiac surgery in patients refusing transfusion compared with those who
do not: a case-matched study. Transfusion. 2015;55(12):2791-2798.
47. Reyes G, Nuche JM, Sarraj A, et al. [Bloodless cardiac surgery in
Jehovah’s witnesses: outcomes compared with a control group]. Rev Esp
Cardiol. 2007;60(7):727-731.
48. Stamou SC, White T, Barnett S, Boyce SW, Corso PJ, Lefrak EA.
Comparisons of cardiac surgery outcomes in Jehovah’s versus
Non-Jehovah’s Witnesses. Am J Cardiol. 2006;98(9):1223-1225.
49. Vaislic C, Bical O, Farge C, et al. Totally minimized extracorporeal
circulation: an important benefit for coronary artery bypass grafting in
Jehovah’s witnesses. Heart Surg Forum. 2003;6(5):307-310.
50. Valle FH, Pivatto Junior F, Gomes BS, Freitas TM, Giaretta V, Gus M.
Cardiac Surgery in Jehovah’s Witness Patients: Experience of a Brazilian
Tertiary Hospital. Braz J Cardiovasc Surg. 2017;32(5):372-377.
51. Willcox TW, Newland RF, Baker RA. Cardiopulmonary bypass management
and acute kidney injury in 118 Jehovah’s Witness patients: a
retrospective propensity-matched multicentre cohort from 30,942
patients. Perfusion. 2020:267659120908119.
52. Jassar AS, Ford PA, Haber HL, et al. Cardiac surgery in Jehovah’s
Witness patients: ten-year experience. Ann Thorac Surg.
2012;93(1):19-25.
53. Ramiaramanana E, Taamalah S, Rabah N, Al Karaky A, Benhadj I,
Vaislic C. Complex Cardiovascular Surgery in Jehovah’s Witness Patients.
Journal of Vascular Medicine and Surgery. 2015;3(3).
54. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and
cardiovascular disease on surgical mortality and morbidity. Lancet.
1996;348(9034):1055-1060.
55. Hogervorst EK, Rosseel PM, van de Watering LM, et al. Intraoperative
Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An
Assessment of Postoperative Outcome Including Patients Refusing Blood
Transfusion. J Cardiothorac Vasc Anesth. 2016;30(2):363-372.
56. Muller H, Ratschiller T, Schimetta W, Meier J, Gombotz H, Zierer A.
Open Heart Surgery in Jehovah’s Witnesses: A Propensity Score Analysis.
Ann Thorac Surg. 2020;109(2):526-533.
57. El-Essawi A, Breitenbach I, Ali K, et al. Minimized perfusion
circuits: an alternative in the surgical treatment of Jehovah’s
Witnesses. Perfusion. 2013;28(1):47-53.
58. Emmert MY, Salzberg SP, Theusinger OM, et al. How good patient blood
management leads to excellent outcomes in Jehovah’s witness patients
undergoing cardiac surgery. Interact Cardiovasc Thorac Surg.
2011;12(2):183-188.
59. Boettcher W, Dehmel F, Redlin M, et al. Complex Cardiac Surgery on
Patients with a Body Weight of Less Than 5 kg without Donor Blood
Transfusion. J Extra Corpor Technol. 2017;49(2):93-97.
60. Viele MK, Weiskopf RB. What can we learn about the need for
transfusion from patients who refuse blood? The experience with
Jehovah’s Witnesses. Transfusion. 1994;34(5):396-401.
61. Ott DA, Cooley DA. Cardiovascular surgery in Jehovah’s Witnesses.
Report of 542 operations without blood transfusion. JAMA.
1977;238(12):1256-1258.
62. Wauthy P, Pierrakos C, Chebli L, Tortora R. Long-term survival and
quality of life in Jehovah’s witnesses after cardiac surgery: a case
control study. BMC Cardiovasc Disord. 2019;19(1):73.